世界のSMAおよびSCID新生児スクリーニングの市場調査レポート　2023年

出版：QYResearch（QYリサーチ）　出版年月：2023年1月

Global Newborn Screening for SMA and SCID Market Research Report 2023
世界のSMAおよびSCID新生児スクリーニングの市場調査レポート　2023年

レポート目次　　お問合せ・ご注文　　価格・納期について

The global Newborn Screening for SMA and SCID market was valued at US$ 129.21 million in 2022 and is anticipated to reach US$ 288.04 million by 2029, witnessing a CAGR of 11.51% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The major global companies of Newborn Screening for SMA and SCID include Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics, and etc. In 2022, the world’s top two vendors accounted for approximately 84% of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Newborn Screening for SMA and SCID, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Newborn Screening for SMA and SCID.
The Newborn Screening for SMA and SCID market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Newborn Screening for SMA and SCID market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Newborn Screening for SMA and SCID companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company
Perkinelmer
Thermo Fisher
ImmunoIVD
Labsystems Diagnostics

Segment by Type
Instruments
Kits
Software

Segment by Application
SCID Screening
SMA Screening

By Region
North America
United States
Canada

Europe
Germany
Spain
France
Sweden
Norway

Other Regions
Asia
MEA

Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Newborn Screening for SMA and SCID companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8: North America, Europe and Other Regions segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 10: The main points and conclusions of the report.

目次

1 Report Overview 1
1.1 Study Scope 1
1.2 Market Analysis by Type 1
1.2.1 Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1
1.2.2 Instruments 4
1.2.3 Kits 4
1.2.4 Software 5
1.3 Market by Application 5
1.3.1 Global Newborn Screening for SMA and SCID Market Growth by Application: 2018 VS 2022 VS 2029 6
1.3.2 SCID Screening 7
1.3.3 SMA Screening 8
1.4 Assumptions and Limitations 9
1.5 Study Objectives 10
1.6 Years Considered 10
2 Global Growth Trends 11
2.1 Global Newborn Screening for SMA and SCID Market Perspective (2018-2029) 11
2.2 Global Newborn Screening for SMA and SCID Growth Trends by Region 13
2.2.1 Global Newborn Screening for SMA and SCID Market Size by Region: 2018 VS 2022 VS 2029 14
2.2.2 Newborn Screening for SMA and SCID Historic Market Size by Region (2018-2023) 15
2.2.3 Newborn Screening for SMA and SCID Forecasted Market Size by Region (2024-2029) 16
2.3 Newborn Screening for SMA and SCID Market Dynamics 16
2.3.1 Newborn Screening for SMA and SCID Industry Trends 16
2.3.2 Newborn Screening for SMA and SCID Market Drivers 17
2.3.3 Newborn Screening for SMA and SCID Market Challenges and Restraints 18
3 Competition Landscape by Key Players 19
3.1 Global Top Newborn Screening for SMA and SCID Players by Revenue 19
3.1.1 Global Top Newborn Screening for SMA and SCID Players by Revenue (2021-2022) 19
3.1.2 Global Newborn Screening for SMA and SCID Revenue Market Share by Players (2021-2022) 19
3.2 Global Newborn Screening for SMA and SCID Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 20
3.3 Global Key Players Ranking by Newborn Screening for SMA and SCID Revenue 21
3.4 Global Newborn Screening for SMA and SCID Market Concentration Ratio 22
3.4.1 Global Newborn Screening for SMA and SCID Market Concentration Ratio (CR3 and HHI) 22
3.4.2 Global Top 3 Companies by Newborn Screening for SMA and SCID Revenue in 2022 23
3.5 Global Key Players of Newborn Screening for SMA and SCID Head office and Area Served 23
3.6 Global Key Players of Newborn Screening for SMA and SCID, Product and Application 24
3.7 Mergers & Acquisitions, Expansion Plans 24
4 Newborn Screening for SMA and SCID Breakdown Data by Type 27
4.1 Global Newborn Screening for SMA and SCID Historic Market Size by Type (2018-2023) 27
4.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2024-2029) 28
5 Newborn Screening for SMA and SCID Breakdown Data by Application 29
5.1 Global Newborn Screening for SMA and SCID Historic Market Size by Application (2018-2023) 29
5.2 Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2024-2029) 30
6 North America 31
6.1 North America Newborn Screening for SMA and SCID Market Size (2018-2029) 31
6.2 North America Newborn Screening for SMA and SCID Market Growth Rate by Country: 2018 VS 2022 VS 2029 31
6.3 North America Newborn Screening for SMA and SCID Market Size by Country (2018-2023) 32
6.4 North America Newborn Screening for SMA and SCID Market Size by Country (2024-2029) 32
6.5 United States 34
6.6 Canada 35
7 Europe 36
7.1 Europe Newborn Screening for SMA and SCID Market Size (2018-2029) 36
7.2 Europe Newborn Screening for SMA and SCID Market Growth Rate by Country: 2018 VS 2022 VS 2029 36
7.3 Europe Newborn Screening for SMA and SCID Market Size by Country (2018-2023) 37
7.4 Europe Newborn Screening for SMA and SCID Market Size by Country (2024-2029) 37
7.5 Germany 39
7.6 France 40
7.7 Spain 41
7.8 Sweden 42
7.9 Norway 43
8 Other Regions 44
8.1 Other Regions Newborn Screening for SMA and SCID Market Size (2018-2029) 44
8.2 Other Regions Newborn Screening for SMA and SCID Market Growth Rate by Country: 2018 VS 2022 VS 2029 44
8.3 Other Regions Newborn Screening for SMA and SCID Market Size by Country (2018-2023) 45
8.4 Other Regions Newborn Screening for SMA and SCID Market Size by Country (2024-2029) 45
8.5 Asia 47
8.6 MEA 48
9 Key Players Profiles 49
9.1 Perkinelmer 49
9.1.1 Perkinelmer Company Details 49
9.1.2 Perkinelmer Business Overview 49
9.1.3 Perkinelmer Newborn Screening for SMA and SCID Introduction 50
9.1.4 Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2021-2022) 52
9.2 Thermo Fisher 53
9.2.1 Thermo Fisher Company Details 53
9.2.2 Thermo Fisher Business Overview 53
9.2.3 Thermo Fisher Newborn Screening for SMA and SCID Introduction 54
9.2.4 Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2021-2022) 55
9.3 ImmunoIVD 55
9.3.1 ImmunoIVD Company Details 55
9.3.2 ImmunoIVD Business Overview 56
9.3.3 ImmunoIVD Newborn Screening for SMA and SCID Introduction 56
9.3.4 ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2021-2022) 57
9.4 Labsystems Diagnostics 58
9.4.1 Labsystems Diagnostics Company Details 58
9.4.2 Labsystems Diagnostics Business Overview 59
9.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Introduction 59
9.4.4 Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2021-2022) 60
10 Analyst’s Viewpoints/Conclusions 62
11 Appendix 63
11.1 Research Methodology 63
11.1.1 Methodology/Research Approach 63
11.1.2 Data Source 66
11.2 Author Details 69
11.3 Disclaimer 71

Table 1. Global Newborn Screening for SMA and SCID Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 2
Table 2. Key Players of Instruments 4
Table 3. Key Players of Kits 5
Table 4. Key Players of Software 5
Table 5. Global Newborn Screening for SMA and SCID Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 6
Table 6. Global Newborn Screening for SMA and SCID Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 14
Table 7. Global Newborn Screening for SMA and SCID Market Size by Region (2018-2023) & (US$ Million) 15
Table 8. Global Newborn Screening for SMA and SCID Market Share by Region (2018-2023) 15
Table 9. Global Newborn Screening for SMA and SCID Forecasted Market Size by Region (2024-2029) & (US$ Million) 16
Table 10. Global Newborn Screening for SMA and SCID Market Share by Region (2024-2029) 16
Table 11. Newborn Screening for SMA and SCID Market Trends 16
Table 12. Newborn Screening for SMA and SCID Market Drivers 17
Table 13. Newborn Screening for SMA and SCID Market Challenges and Restraints 18
Table 14. Global Newborn Screening for SMA and SCID Revenue by Players (2021-2022) & (US$ Million) 19
Table 15. Global Newborn Screening for SMA and SCID Market Share by Players (2021-2022) 19
Table 16. Global Top Newborn Screening for SMA and SCID Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Newborn Screening for SMA and SCID as of 2022) 21
Table 17. Ranking of Global Top Newborn Screening for SMA and SCID Companies by Revenue (US$ Million) in 2022 21
Table 18. Global 3 Largest Players Market Share by Newborn Screening for SMA and SCID Revenue (CR3 and HHI) & (2021-2022) 22
Table 19. Global Key Players of Newborn Screening for SMA and SCID, Headquarters and Area Served 23
Table 20. Global Key Players of Newborn Screening for SMA and SCID, Product and Application 24
Table 21. Mergers & Acquisitions, Expansion Plans 24
Table 22. Global Newborn Screening for SMA and SCID Market Size by Type (2018-2023) & (US$ Million) 27
Table 23. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2018-2023) 27
Table 24. Global Newborn Screening for SMA and SCID Forecasted Market Size by Type (2024-2029) & (US$ Million) 28
Table 25. Global Newborn Screening for SMA and SCID Revenue Market Share by Type (2024-2029) 28
Table 26. Global Newborn Screening for SMA and SCID Market Size by Application (2018-2023) & (US$ Million) 29
Table 27. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2018-2023) 29
Table 28. Global Newborn Screening for SMA and SCID Forecasted Market Size by Application (2024-2029) & (US$ Million) 30
Table 29. Global Newborn Screening for SMA and SCID Revenue Market Share by Application (2024-2029) 30
Table 30. North America Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 31
Table 31. North America Newborn Screening for SMA and SCID Market Size by Country (2018-2023) & (US$ Million) 32
Table 32. North America Newborn Screening for SMA and SCID Market Size by Country (2024-2029) & (US$ Million) 32
Table 33. Europe Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 36
Table 34. Europe Newborn Screening for SMA and SCID Market Size by Country (2018-2023) & (US$ Million) 37
Table 35. Europe Newborn Screening for SMA and SCID Market Size by Country (2024-2029) & (US$ Million) 37
Table 36. Other Regions Newborn Screening for SMA and SCID Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 44
Table 37. Other Regions Newborn Screening for SMA and SCID Market Size by Country (2018-2023) & (US$ Million) 45
Table 38. Other Regions Newborn Screening for SMA and SCID Market Size by Country (2024-2029) & (US$ Million) 45
Table 39. Perkinelmer Company Details 49
Table 40. Perkinelmer Business Overview 49
Table 41. Perkinelmer Newborn Screening for SMA and SCID Product 50
Table 42. Perkinelmer Revenue in Newborn Screening for SMA and SCID Business (2021-2022) & (US$ Million) 52
Table 43. Thermo Fisher Company Details 53
Table 44. Thermo Fisher Business Overview 53
Table 45. Thermo Fisher Newborn Screening for SMA and SCID Product 54
Table 46. Thermo Fisher Revenue in Newborn Screening for SMA and SCID Business (2021-2022) & (US$ Million) 55
Table 47. ImmunoIVD Company Details 55
Table 48. ImmunoIVD Business Overview 56
Table 49. ImmunoIVD Newborn Screening for SMA and SCID Product 56
Table 50. ImmunoIVD Revenue in Newborn Screening for SMA and SCID Business (2021-2022) & (US$ Million) 57
Table 51. Labsystems Diagnostics Company Details 58
Table 52. Labsystems Diagnostics Business Overview 59
Table 53. Labsystems Diagnostics Newborn Screening for SMA and SCID Product 59
Table 54. Labsystems Diagnostics Revenue in Newborn Screening for SMA and SCID Business (2021-2022) & (US$ Million) 60
Table 55. Research Programs/Design for This Report 63
Table 56. Key Data Information from Secondary Sources 67
Table 57. Key Data Information from Primary Sources 68
Table 58. Authors List of This Report 69
Table 59. QYR Business Unit and Senior & Team Lead Analysts 69

List of Figures

Figure 1. Product Picture of Newborn Screening for SMA and SCID 1
Figure 2. Global Newborn Screening for SMA and SCID Market Size Comparison by Type (2023-2029) & (US$ Million) 2
Figure 3. Global Newborn Screening for SMA and SCID Market Share by Type: 2022 3
Figure 4. Global Newborn Screening for SMA and SCID Market Share by Type: 2029 3
Figure 5. Instruments Features 4
Figure 6. Kits Features 4
Figure 7. Software Features 5
Figure 8. Global Newborn Screening for SMA and SCID Market Size by Application (2023-2029) & (US$ Million) 6
Figure 9. Global Newborn Screening for SMA and SCID Market Share by Application: 2022 7
Figure 10. Global Newborn Screening for SMA and SCID Market Share by Application: 2029 7
Figure 11. SCID Screening Case Studies 8
Figure 12. SMA Screening Case Studies 8
Figure 13. Newborn Screening for SMA and SCID Report Years Considered 10
Figure 14. Global Newborn Screening for SMA and SCID Market Size (US$ Million), Year-over-Year: 2018-2029 12
Figure 15. Global Newborn Screening for SMA and SCID Market Size, (US$ Million), 2018 VS 2023 VS 2029 13
Figure 16. Global Newborn Screening for SMA and SCID Market Share by Region: 2022 14
Figure 17. Global Newborn Screening for SMA and SCID Market Share by Region: 2029 15
Figure 18. Global Newborn Screening for SMA and SCID Market Share by Players in 2022 20
Figure 19. The Top 3 Players Market Share by Newborn Screening for SMA and SCID Revenue in 2022 23
Figure 20. North America Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million) 31
Figure 21. North America Newborn Screening for SMA and SCID Market Share by Country (2018-2029) 33
Figure 22. United States Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million) 34
Figure 23. Canada Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million) 35
Figure 24. Europe Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million) 36
Figure 25. Europe Newborn Screening for SMA and SCID Market Share by Country (2018-2029) 38
Figure 26. Germany Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million) 39
Figure 27. France Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million) 40
Figure 28. Spain Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million) 41
Figure 29. Sweden Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million) 42
Figure 30. Norway Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million) 43
Figure 31. Other Regions Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million) 44
Figure 32. Other Regions Newborn Screening for SMA and SCID Market Share by Country (2018-2029) 46
Figure 33. Asia Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million) 47
Figure 34. MEA Newborn Screening for SMA and SCID Market Size YoY Growth (2018-2029) & (US$ Million) 48
Figure 35. Perkinelmer Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021-2022) 52
Figure 36. Thermo Fisher Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021-2022) 55
Figure 37. ImmunoIVD Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021-2022) 58
Figure 38. Labsystems Diagnostics Revenue Growth Rate in Newborn Screening for SMA and SCID Business (2021-2022) 61
Figure 39. Bottom-up and Top-down Approaches for This Report 65
Figure 40. Data Triangulation 66
Figure 41. Key Executives Interviewed 68